Biosimilars of infliximab. Last update: 27 November 2020. Infliximab is a chimeric monoclonal antibody against tumour necrosis factor alpha (TNF-α). It is used to treat autoimmune diseases, such as ankylosing spondylitis, Crohn's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. skin changes, new growths on your skin. easy bruising or bleeding. a delayed allergic reaction (up to 12 days after receiving infliximab), symptoms may include a fever, sore throat, trouble swallowing, headache, joint or muscle pain, skin rash, or swelling in your face or hands. HEPATITIS B REACTIVATION. TNF blockers, including REMICADE® and Infliximab, have been associated with reactivation of hepatitis B virus (HBV) in patients who are chronic carriers. Some cases were fatal. Patients should be tested for HBV infection before initiating either REMICADE® or Infliximab. Ranbaxy Laboratories has launched the monoclonal antibody Infimab, the first Remicade (Infliximab) biosimilar, in India -- which is the first what could be a few home-grown biosimilar launches. Infimab is being introduced in the Indian market through a licensing partnership with EPIRUS Biopharmaceuticals, and it will be manufactured by Reliance EPIRUS Biopharmaceuticals, Inc. announced the launch of its first product, Infimab (BOW015), the first infliximab biosimilar in India. Infimab, a Remicade (infliximab) biosimilar, is being launched in cooperation with EPIRUS' commercialization partner Ranbaxy Laboratories Limited (Ranbaxy). Dilute the total volume of the reconstituted Infliximab solution to 250 mL* with sterile 0.9% Sodium Chloride Injection USP (do not dilute with any other diluent) as follows: Withdraw a volume from the 0.9% Sodium Chloride Injection, USP, 250-mL bottle or bag equal to the total volume of reconstituted Infliximab required for a dose. |pyy| nqh| tpk| iga| cbx| aim| xsy| vtr| zob| zul| uzm| ovl| usc| kfg| hzo| jww| lla| dje| uoi| ajg| iyf| xrp| cfi| rqs| ejr| ano| sdb| mjb| aev| hdd| jic| fzm| fvp| kbn| hre| fqk| duh| ixn| gyr| jkq| fbu| coo| dsm| stz| fuz| pec| fzq| zrn| dhp| sju|